About Purposeful
Purposeful is a company based in Athens (Greece) founded in 2000. It operates as a AI-as-a-Service, and Professional Services. Purposeful has raised $293.9 thousand across 2 funding rounds from investors including PharOS and Metavallon. Purposeful offers products and services including Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery. Purposeful operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Athens, Greece
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$293.9 K (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
PharOS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Purposeful
Purposeful offers a comprehensive portfolio of products and services, including Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drugs are repurposed to treat rare genetic disorders.
AI is utilized to rediscover drugs for diseases.
Funding Insights of Purposeful
Purposeful has successfully raised a total of $293.9K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(25 Sep 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Seed - Purposeful | Valuation | PharOS |
|
| Sep, 2018 | Amount | Seed - Purposeful | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Purposeful
Purposeful has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include PharOS and Metavallon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm and startup accelerator
|
Founded Year | Domain | Location | |
|
Generic drugs are manufactured and supplied by PharOS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Purposeful
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Purposeful
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Purposeful Comparisons
Competitors of Purposeful
Purposeful operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Purposeful
When was Purposeful founded?
Purposeful was founded in 2000 and raised its 1st funding round 18 years after it was founded.
Where is Purposeful located?
Purposeful is headquartered in Athens, Greece.
Is Purposeful a funded company?
Purposeful is a funded company, having raised a total of $293.9K across 2 funding rounds to date. The company's 1st funding round was a Seed of $293.9K, raised on Sep 25, 2018.
What does Purposeful do?
Purposeful is focused on discovering new treatments and developing pharmaceutical products for rare diseases by repurposing already marketed drugs. The company employs AI-driven approaches to revisit both rare and common diseases, aiming to reverse disease phenotypes. Collaborations with organizations like FRAXA, BIOEMTECH, and Leo Pharma Ltd are maintained to identify and validate drug repurposing candidates across various conditions such as Fragile X Syndrome, Glioblastoma, and dermatology indications. The healthcare sector, particularly rare disease treatment, is the primary area of operation.
Who are the top competitors of Purposeful?
Purposeful's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Purposeful offer?
Purposeful offers Drug Repurposing for Rare Diseases and AI-Driven Drug Discovery.
Who are Purposeful's investors?
Purposeful has 2 investors. Key investors include PharOS, and Metavallon.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.